Westford USA, Feb. 05, 2024 (GLOBE NEWSWIRE) -- According to SkyQuest, the growing popularity and rising demand for biopharmaceuticals, including vital products such as monoclonal antibodies, vaccines ...

CMOs are working hard to improve performance by investigating new technologies for filtration and purification. Downstream processing problems are not unique to CMOs, of course. It seems, however, ...

Downstream Processing Market · GlobeNewswire Inc. Dublin, Feb. 20, 2025 (GLOBE NEWSWIRE) -- The "Downstream Processing - Global Strategic Business Report" has been added to ResearchAndMarkets.com's ...

Biologics comprise a huge variety of different molecules, activities, and applications and mostly try to mimic functions of natural molecules. Generally, they are of a rather complex nature and often ...

Biomanufacturing might appear to be centered around the cell line, which does enjoy a certain pride of place, ensconced as it is in the bioreactor, where conditions are carefully monitored and ...

Biomanufacturing is different from other processing industries. It is less able to sustain continuous end-to-end flows because it must contend with unique technical, practical, regulatory, and ...

Downstream Processing: A Critical Step in the Development of Bioproducts for A Circular Economy 11.3% CAGR Market Growth by 2032 | FMI Insight The extraction, purification, and refinement of important ...

With the recent FDA approval of the CAR T-cell therapies Kymriah ® from Novartis and Yescarta ® from Kite Pharma, there has been a renewed interest in bioprocessing and the manufacturing facilities ...

Drug development and manufacturing have undergone a seismic shift in the last two decades, 1 from blockbuster small molecules to highly personalized biologics 2 and cell and gene therapies. Because ...

Washing and concentrating cells is one of the main steps in cell therapy research and manufacturing. During this step, expanded cell cultures are concentrated and washed in suitable buffer solutions ...

Over the last few years, the number of recombinant pharmaceutical products that have entered the regulatory fray to gain approval for marketing has grown rapidly, and is now in the hundreds. As ...